Photo: Omar Marques/SOPA Images/LightRocket via Getty Images

Bitcoin, left for dead by many investors, has been on a tear of late and is attracting significant interest from speculators.

Why it matters: Traders raised their bullish bets on bitcoin to the highest level in 11 months on Monday, data from cryptocurrency exchange Bitfinex shows, and traders are continuing to pile into the cryptocurrency.

By the numbers: Long positions have risen by 35% in the last three weeks, while short positions have remained largely unchanged. Long positions are near historic highs, but remain at least 8% below the record high registered on March 26, 2018, Coindesk reports.

What's next? Yves Lamoureux, president and chief behavioral strategist of research firm Lamoureux & Co., tells Axios his models show the rally in Bitcoin is going to grow tenfold. He points to the Fed's dovish turn late last year that will eventually lead the U.S. central bank to more quantitative easing and an overheated U.S. economy, prompting major flows into Bitcoin.

  • Further, Lamoureux says, "the Fed is slowly eroding its credibility," leading to more upside for assets like cryptocurrencies.
  • "Our money flow pressure indicates upside for Bitcoin until mid-2020."

Lamoureux called for a rally in Bitcoin to $25,000 per coin in February 2017 when it was trading at around $950.

  • "Whether tulips, housing or tech stocks, bubbles require public participation," he wrote at the time. "And as blockchain becomes more ubiquitous, it lends credibility to the technology behind bitcoin. We feel that digital currencies, such as bitcoin, have now entered a similar cycle."

Yes, but: The cryptocurrency peaked in December 2017 at just under $20,000, short of Lamoureux's prediction. Bitcoin bulls (many of whom held large amounts of the cryptocurrency) also have made a number of outlandish predictions in the past, from Tyler Winklevoss' $100,000 a coin prediction to John McAfee's $1 million.

Still: Bitcoin is trading at its highest in more than 5 weeks at $3,911.

Go deeper: Why Bitcoin's fall gives the planet a breather

Go deeper

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 6 p.m. ET: 13,203,571 — Total deaths: 575,201 — Total recoveries — 7,331,068Map.
  2. U.S.: Total confirmed cases as of 6 p.m. ET: 3,407,798 — Total deaths: 136,252 — Total recoveries: 1,031,939 — Total tested: 41,004,275Map.
  3. Politics: Biden welcomes Trump wearing mask in public but warns "it’s not enough"
  4. Public health: Four former CDC heads say Trump's undermining of agency puts lives at risk — CDC director: U.S. could get coronavirus "under control" in 4–8 weeks if all wear masks.

Bank CEOs brace for worsening economic scenario

JPMorgan CEO Jamie Dimon. Photo: J. Lawler Duggan/For The Washington Post via Getty Images

Wells Fargo swung to its first loss since the financial crisis — while JPMorgan Chase and Citigroup reported significantly lower profits from a year earlier — as the banks set aside billions of dollars more in the second quarter for loans that may go bad.

Why it matters: The cumulative $28 billion in loan loss provisions that banks have so far announced they’re reserving serves as a signal they’re preparing for a colossal wave of loan defaults as the economy slogs through a coronavirus-driven downturn.

2 hours ago - Health

Moderna's vaccine spurred immune system response to coronavirus

Moderna's stock rose 16% after hours on this news. Photo: Jakub Porzycki/NurPhoto via Getty Images

Healthy volunteers who took Moderna's coronavirus vaccine candidate appeared to generate an immune system response to the virus, and there were "no trial-limiting safety concerns," according to a new study published in the New England Journal of Medicine.

Why it matters: The phase one trial is still small and does not definitively determine how effective the vaccine is. But Anthony Fauci of the National Institutes of Health, which is running the trial, told the Wall Street Journal that these data make it "pretty clear that this vaccine is capable of inducing quite good [levels] of neutralizing antibodies."